Acciones Goodbody Health Canadian Securities Exchange
Acciones
SWEL
CA3821591011
Farmacéuticos
Ventas 2020 | 1,99 M 2,5 M 3,42 M 2,32 M | Ventas 2021 | 17,06 M 21,42 M 29,28 M 19,85 M | Capitalización | 13,76 M 17,27 M 23,61 M 16,01 M |
---|---|---|---|---|---|
Resultado Neto 2020 | -4 M -5,02 M -6,86 M -4,65 M | Resultado Neto 2021 | -2 M -2,51 M -3,43 M -2,33 M | VE / Ventas 2020 | 5,41 x |
Posición de caja neta 2020 | 1,37 M 1,72 M 2,36 M 1,6 M | Posición de caja neta 2021 | 5,73 M 7,2 M 9,84 M 6,67 M | VE / Ventas 2021 | 0,47 x |
P/E ratio 2020 |
-1,4
x | P/E ratio 2021 |
-5,64
x | Empleados | - |
Rendimiento 2020 * |
-
| Rendimiento 2021 |
-
| Flotante | 70,26 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 26/01/21 |
Geremy Thomas
FOU | Founder | 64 | 14/02/11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 14/02/11 |
George Thomas
CEO | Chief Executive Officer | 35 | 26/01/21 |
Anne Tew
SEC | Corporate Secretary | - | 01/11/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+43,17 % | 6157,69 M | |
-14,69 % | 4462,61 M | |
-8,17 % | 3268,89 M | |
+6,95 % | 3197,81 M | |
-1,76 % | 2599,21 M | |
+50,20 % | 1975,39 M | |
-7,85 % | 1697,69 M | |
-0,40 % | 1661,22 M | |
-9,91 % | 1609,03 M |